001     282581
005     20251218103444.0
024 7 _ |a 10.1186/s13195-025-01911-7
|2 doi
024 7 _ |a pmid:41331692
|2 pmid
024 7 _ |a pmc:PMC12670842
|2 pmc
037 _ _ |a DZNE-2025-01341
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Doblhammer, Gabriele
|0 P:(DE-2719)2811246
|b 0
|e First author
245 _ _ |a Declining incidence but little change in years lived with dementia in two German cohorts diagnosed with dementia in 2006/2008 and 2016/2018.
260 _ _ |a London
|c 2025
|b BioMed Central
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1764938071_11990
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a We examined whether changes in dementia incidence and mortality have led to changes in the average number of years lived with and without dementia over a ten-year period in Germany.We calculated dementia rates using two samples of people aged 65 + from a German health insurance company, each comprising more than 100,000 people in 2006/08 and 2016/18. We examined time trends using negative binomial regression models and estimated average life expectancy (ALE) for people with and without dementia by fitting a three-stage Markov health-disease model.Dementia incidence rates decreased by 7.3% in men and by 9.7% in women. Dementia mortality rates fell by 12% in men but did not change significantly in women. Non-dementia mortality rates fell by 7% in both men and women. The combined changes resulted in stable total ALE in men and increasing total ALE in women, whereas ALE with dementia increased in men and remained stable in women.The observed decline in dementia incidence did not translate into a reduction in the burden of the disease.The online version contains supplementary material available at 10.1186/s13195-025-01911-7.
536 _ _ |a 354 - Disease Prevention and Healthy Aging (POF4-354)
|0 G:(DE-HGF)POF4-354
|c POF4-354
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Dementia incidence
|2 Other
650 _ 7 |a Dementia mortality
|2 Other
650 _ 7 |a Germany
|2 Other
650 _ 7 |a Life expectancy
|2 Other
650 _ 7 |a Time trends
|2 Other
700 1 _ |a Erlangsen, Annette
|0 0000-0003-3475-0558
|b 1
700 1 _ |a Fink, Anne
|0 P:(DE-2719)2241493
|b 2
700 1 _ |a Canudas-Romo, Vladimir
|0 0000-0001-6532-0089
|b 3
773 _ _ |a 10.1186/s13195-025-01911-7
|g Vol. 17, no. 1, p. 255
|0 PERI:(DE-600)2506521-X
|n 1
|p 255
|t Alzheimer's research & therapy
|v 17
|y 2025
|x 1758-9193
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/282581/files/DZNE-2025-01341.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/282581/files/DZNE-2025-01341.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:282581
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2811246
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2241493
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-354
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Prevention and Healthy Aging
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-13
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-13
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ALZHEIMERS RES THER : 2022
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-04-10T15:32:54Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-04-10T15:32:54Z
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-13
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-13
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-13
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-13
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b ALZHEIMERS RES THER : 2022
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-13
920 1 _ |0 I:(DE-2719)1012002
|k AG Doblhammer
|l Demographic Studies
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1012002
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21